Kendall Capital Management Pfizer Inc Transaction History

Kendall Capital Management

$403 Million
Q3 2025

A detailed history of Kendall Capital Management transactions in Pfizer Inc stock. As of the latest transaction made, Kendall Capital Management holds 26,515 shares of PFE stock, worth $664,996. This represents 0.17% of its overall portfolio holdings.

Number of Shares

26,515

Previous 17,400 52.39%

Holding current value

$664,996

Previous $421,000 60.33%

% of portfolio

0.17%

Previous 0.12%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$23.29 - $25.88 $212,288 - $235,896	9,115 Added 52.39%	26,515 $675,000
Q2 2025 Jul 16, 2025	BUY	$21.59 - $24.84 $375,666 - $432,216	17,400 New	17,400 $421,000
Q3 2024 Nov 08, 2024	SELL	$27.7 - $31.39 $63,710 - $72,197	-2,300 Reduced 17.56%	10,800 $312,000
Q2 2024 Aug 12, 2024	SELL	$25.26 - $29.6 $507,119 - $594,249	-20,076 Reduced 60.51%	13,100 $366,000
Q1 2024 May 10, 2024	SELL	$25.89 - $29.73 $387,961 - $445,504	-14,985 Reduced 31.11%	33,176 $920,000

Q4 2023 Jan 26, 2024	SELL	$26.13 - $33.94 $153,121 - $198,888	-5,860 Reduced 10.85%	48,161 $1.39 Million
Q3 2023 Oct 31, 2023	BUY	$32.09 - $37.51 $150,502 - $175,921	4,690 Added 9.51%	54,021 $1.79 Million
Q2 2023 Jul 28, 2023	SELL	$36.12 - $41.79 $54,541 - $63,102	-1,510 Reduced 2.97%	49,331 $1.81 Million
Q1 2023 May 11, 2023	BUY	$39.39 - $51.28 $107,022 - $139,327	2,717 Added 5.65%	50,841 $2.07 Million
Q4 2022 Jan 30, 2023	BUY	$41.75 - $54.5 $215,263 - $281,002	5,156 Added 12.0%	48,124 $2.47 Million
Q3 2022 Nov 02, 2022	BUY	$43.76 - $53.42 $193,025 - $235,635	4,411 Added 11.44%	42,968 $1.88 Million
Q2 2022 Jul 29, 2022	BUY	$46.53 - $55.17 $238,885 - $283,242	5,134 Added 15.36%	38,557 $2.02 Million
Q1 2022 May 06, 2022	BUY	$45.75 - $56.69 $47,580 - $58,957	1,040 Added 3.21%	33,423 $1.73 Million
Q4 2021 Jan 28, 2022	SELL	$41.32 - $61.25 $2,066 - $3,062	-50 Reduced 0.15%	32,383 $1.91 Million
Q3 2021 Nov 05, 2021	SELL	$39.25 - $50.42 $1,216 - $1,563	-31 Reduced 0.1%	32,433 $1.4 Million
Q2 2021 Jul 30, 2021	SELL	$35.91 - $40.68 $33,037 - $37,425	-920 Reduced 2.76%	32,464 $1.27 Million
Q1 2021 May 05, 2021	SELL	$33.49 - $37.77 $6,698 - $7,554	-200 Reduced 0.6%	33,384 $1.21 Million
Q4 2020 Feb 08, 2021	SELL	$33.47 - $42.56 $5,020 - $6,384	-150 Reduced 0.44%	33,584 $1.24 Million
Q3 2020 Oct 22, 2020	SELL	$31.75 - $37.25 $10,763 - $12,627	-339 Reduced 0.99%	33,734 $1.24 Million
Q2 2020 Jul 30, 2020	SELL	$30.12 - $36.54 $41,565 - $50,425	-1,380 Reduced 3.89%	34,073 $1.11 Million
Q1 2020 Apr 27, 2020	SELL	$27.03 - $38.62 $85,171 - $121,691	-3,151 Reduced 8.16%	35,453 $1.16 Million
Q4 2019 Jan 24, 2020	BUY	$32.92 - $37.36 $64,358 - $73,038	1,955 Added 5.33%	38,604 $1.51 Million
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $31,677 - $41,076	975 Added 2.73%	36,649 $1.32 Million
Q2 2019 Aug 09, 2019	SELL	$36.98 - $41.52 $54,730 - $61,449	-1,480 Reduced 3.98%	35,674 $1.55 Million
Q1 2019 May 08, 2019	BUY	$37.5 - $41.2 $2,062 - $2,266	55 Added 0.15%	37,154 $1.58 Million
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $24,774 - $28,245	644 Added 1.77%	37,099 $1.62 Million
Q3 2018 Oct 29, 2018	SELL	$34.47 - $41.81 $66,320 - $80,442	-1,924 Reduced 5.01%	36,455 $1.61 Million
Q2 2018 Jul 27, 2018	BUY	$32.98 - $35.16 $219,976 - $234,517	6,670 Added 21.04%	38,379 $1.39 Million
Q1 2018 May 14, 2018	BUY	$31.91 - $37.02 $98,601 - $114,391	3,090 Added 10.8%	31,709 $1.13 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $951,867 - $1.01 Million	28,619	28,619 $1.04 Million

Others Institutions Holding PFE

# of Institutions

3,355

Shares Held

3.57B

Call Options Held

86.1M

Put Options Held

105M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kendall Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Kendall Capital Management with notifications on news.

Account

Kendall Capital Management Pfizer Inc Transaction History